GB1338906A - Amino purine derivatives - Google Patents

Amino purine derivatives

Info

Publication number
GB1338906A
GB1338906A GB2751373A GB1338906DA GB1338906A GB 1338906 A GB1338906 A GB 1338906A GB 2751373 A GB2751373 A GB 2751373A GB 1338906D A GB1338906D A GB 1338906DA GB 1338906 A GB1338906 A GB 1338906A
Authority
GB
United Kingdom
Prior art keywords
purine derivatives
amino purine
diamidopurine
nov
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2751373A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of GB1338906A publication Critical patent/GB1338906A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GB2751373A 1969-11-17 1970-11-16 Amino purine derivatives Expired GB1338906A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
GB1338906A true GB1338906A (en) 1973-11-28

Family

ID=25369972

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5450270A Expired GB1338905A (en) 1969-11-17 1970-11-16 Amino purine derivatives
GB2751373A Expired GB1338906A (en) 1969-11-17 1970-11-16 Amino purine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB5450270A Expired GB1338905A (en) 1969-11-17 1970-11-16 Amino purine derivatives

Country Status (26)

Country Link
US (1) US3666856A (fr)
JP (1) JPS5429520B1 (fr)
AT (1) AT309696B (fr)
BE (1) BE759011A (fr)
BR (1) BR6915136D0 (fr)
CA (1) CA967564A (fr)
CH (2) CH555344A (fr)
CS (1) CS181701B2 (fr)
DE (1) DE2056327C2 (fr)
DK (1) DK128117B (fr)
ES (2) ES385590A1 (fr)
FI (1) FI54315C (fr)
FR (1) FR2073364B1 (fr)
GB (2) GB1338905A (fr)
HU (1) HU163812B (fr)
IE (1) IE34737B1 (fr)
IL (1) IL35658A (fr)
LU (1) LU62071A1 (fr)
MC (1) MC869A1 (fr)
NL (1) NL171589C (fr)
NO (1) NO128156B (fr)
PL (1) PL81167B1 (fr)
SE (1) SE385374B (fr)
YU (2) YU35033B (fr)
ZA (1) ZA707722B (fr)
ZM (1) ZM12970A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
ATE128141T1 (de) * 1988-03-16 1995-10-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (fr) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Procédés pour le traitement de neuropathie périphérique induite par une pathologie et des états connexes
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
DE2056327A1 (de) 1971-06-03
ES385590A1 (es) 1973-10-01
ZA707722B (en) 1972-06-28
AT309696B (de) 1973-08-27
IE34737L (en) 1971-05-17
FR2073364A1 (fr) 1971-10-01
MC869A1 (fr) 1971-09-28
DK128117B (da) 1974-03-04
NO128156B (fr) 1973-10-08
LU62071A1 (fr) 1971-08-12
ZM12970A1 (en) 1972-07-21
FI54315B (fi) 1978-07-31
IE34737B1 (en) 1975-08-06
CH555833A (de) 1974-11-15
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
YU35033B (en) 1980-06-30
IL35658A0 (en) 1971-01-28
CH555344A (de) 1974-10-31
YU280670A (en) 1979-12-31
BE759011A (fr) 1971-05-17
NL171589C (nl) 1983-04-18
CS181701B2 (en) 1978-03-31
NL7016766A (fr) 1971-05-19
FI54315C (fi) 1978-11-10
FR2073364B1 (fr) 1974-03-22
HU163812B (fr) 1973-10-27
JPS5429520B1 (fr) 1979-09-25
NL171589B (nl) 1982-11-16
US3666856A (en) 1972-05-30
BR6915136D0 (pt) 1973-04-19
SE385374B (sv) 1976-06-28
PL81167B1 (fr) 1975-08-30
IL35658A (en) 1974-10-22
DE2056327C2 (de) 1984-10-11
CA967564A (en) 1975-05-13
YU35034B (en) 1980-06-30
YU201978A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
GB1338906A (en) Amino purine derivatives
AU469729B2 (en) Stud finder
GB1333248A (en) Reactive dyestuffs
GB1150987A (en) Sensitization of Light-Sensitive Polymers
GB1258026A (fr)
ES418527A1 (es) Procedimiento para la obtencion de colorantes reactivos concelulosa.
GB1138465A (en) Pigment compositions
GB1128519A (en) Improvements in or relating to the electro-deposition of nickel
GB1419631A (en) Bonding process
ES393986A1 (es) Un procedimiento para la preparacion de derivados de alco- hol 3,4-dihidroxibencilico.
GB1295685A (fr)
GB1296415A (fr)
GB1164898A (en) Improvements in or relating to Substituted Propanols and the Manufacture thereof
GB1301555A (fr)
GB1173715A (en) Diphenyl-Indolyl-Methane Dyestuffs
GB1149218A (en) Compounds containing a furan-heterocyclic fused ring system
GB1164698A (en) Production of Pyrone Derivatives
GB1128217A (en) Sulphonyl phenols and thiophenols and their use as herbicides
ES423950A1 (es) Procedimiento para la preparacion de 3 - carbetoxihidrazino- piridazinas - 6 - sustituidas.
GB1223882A (en) 5-benzylpyrimidine derivatives
GB1256328A (en) A process for the preparation of dilithio (perfluoroalkylethylsilyl) neocarboranes
ES374657A1 (es) Un proceso para la preparacion de nuevos derivados susti- tuidos de 1,1-dicloro-alqueno-1-.
ES348051A1 (es) Procedimiento para la preparacion de colorantes reactivos.
GB1255892A (en) Substituted urea derivatives
GB1252436A (fr)

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee